Measurement of PD-1, TIM-3 and LAG-3 protein in non-small cell lung carcinomas (NSCLCs) with acquired resistance to PD-1 axis blockers.

被引：4
|
作者：
Datar, Ila
Mani, Nikita
Henick, Brian S.
Wurtz, Anna
Kaftan, Edward
Herbst, Roy S.
Rimm, David L.
Gettinger, Scott N.
Politi, Katerina A.
Schalper, Kurt Alex
机构：
[1] Yale Sch Med, New Haven, CT USA
[2] Yale Univ, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e14611
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14611
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Immune Co-inhibitory Receptors CTLA-4, PD-1, TIGIT, LAG-3, and TIM-3 in Upper Tract Urothelial Carcinomas: A Large Cohort Study
    Jin, Shengming
    Shang, Zhi
    Wang, Wenwen
    Gu, Chengyuan
    Wei, Yu
    Zhu, Yu
    Yang, Chen
    Zhang, Tiantian
    Zhu, Yao
    Zhu, Yiping
    Wu, Junlong
    Ye, Dingwei
    JOURNAL OF IMMUNOTHERAPY, 2023, 46 (04) : 154 - 159
  • [42] Research progression of PD-1/PD-L1 in non-small cell lung cancer
    Xing Liu
    Xiaodong Xie
    Oncology and Translational Medicine, 2017, 3 (03) : 111 - 115
  • [43] PD-1 and PD-L1 inhibitor toxicities in non-small cell lung cancer
    Shankar, Bairavi
    Naidoo, Jarushka
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S4034 - S4037
  • [44] Engineering and expression of constitutive activators of the PD-1 and LAG-3 signaling pathways
    Chocarro, L.
    Garcia Granda, M. J.
    Zuazo, M.
    Arasanz, H.
    Bocanegra, A.
    Blanco, E.
    Hernandez Saez, C.
    Fernandez Hinojal, G.
    Vera, R.
    Kochan, G.
    Escors, D.
    ANNALS OF ONCOLOGY, 2020, 31 : S250 - S250
  • [45] Pseudoprogression in a patient with metastatic melanoma treated with PD-1 and LAG-3 inhibition
    Wu, Lawrence W.
    Tao, Jacqueline J.
    McDonnell, Diana
    Izar, Benjamin
    MELANOMA RESEARCH, 2024, 34 (04) : 382 - 385
  • [46] Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinoma
    Malinga, Nonkululeko Z.
    Siwele, Shalete C.
    Steel, Helen C.
    Kwofie, Luyanda L., I
    Meyer, Pieter W. A.
    Smit, Teresa
    Anderson, Ronald
    Rapoport, Bernardo L.
    Kgokolo, Mahlatse C. M.
    TRANSLATIONAL ONCOLOGY, 2022, 19
  • [47] Association of Polymorphisms in PD-1 and LAG-3 Genes with Acute Myeloid Leukemia
    Mansour, Lamjed
    Alqahtani, Mashael
    Aljuaimlani, Ali
    Al-Tamimi, Jameel
    Al-Harbi, Nouf
    Alomar, Suliman
    MEDICINA-LITHUANIA, 2024, 60 (05):
  • [48] The checkpoint molecules LAG-3 and PD-1 synergize to maintain tolerance to tumors
    Goldberg, Monica V.
    Woo, Seng-Ryong
    Bankoti, Jaishree
    Selby, Mark
    Nirschi, Christopher J.
    Bettini, Matthew L.
    Vogel, Peter
    Grosso, Joseph F.
    Netto, George
    Chaux, Alcides
    Smeltzer, Matthew
    Workman, Creg J.
    Pardoll, Drew M.
    Korman, Alan J.
    Vignali, Dario A. A.
    Drake, Charles G.
    CANCER RESEARCH, 2011, 71
  • [49] Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1, and TIM-3 are markedly increased in basal cell carcinoma
    Rapoport, Bernardo Leon
    Malinga, Nonkululeko
    Siwele, Shalete
    Steel, Helen C.
    Kwofie, Luyanda Li
    Meyer, Pieter
    Smit, Teresa
    Anderson, Ronald
    Kgokolo, Mahlatse
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] Association of T-Cell Exhaustion Markers, PD-1, TIM-3 and LAG-3 with Liver Cirrhosis, and Responses to Therapy in Chronic HCV-Infected Patients
    Abdel-Hameed, Enass A.
    Rouster, Susan D.
    Shata, Mohamed Tarek M.
    Sherman, Kenneth E.
    HEPATOLOGY, 2016, 64 : 744A - 745A
12345